Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas

Paik, P. K., Luo, J., Ai, N., Kim, R., Ahn, L., Biswas, A., Coker, C., Ma, W., Wong, P., Buonocore, D. J., Lai, W. V., Chaft, J. E., Acharyya, S., Massagué, J., & Kris, M. G. (2022). Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-33719-6

Authors:

Paul K. Paik

Jia Luo

Ni Ai

Rachel Kim

Linda Ahn

Anup Biswas

Courtney Coker

Wanchao Ma

Phillip Wong

Darren J. Buonocore

W. Victoria Lai